Pages that link to "Q82845190"
Jump to navigation
Jump to search
The following pages link to IgMA-enriched immunoglobulin in neutropenic patients with sepsis syndrome and septic shock: a randomized, controlled, multiple-center trial (Q82845190):
Displaying 17 items.
- Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers (Q24186274) (← links)
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock (Q24198059) (← links)
- Intravenous immunoglobulins for the treatment of infections in patients with haematological cancers (Q24236448) (← links)
- Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 (Q29615429) (← links)
- Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial (Q34739999) (← links)
- The Japanese guidelines for the management of sepsis (Q35107094) (← links)
- How to treat severe infections in critically ill neutropenic patients? (Q35457899) (← links)
- Bench-to-bedside review: Immunoglobulin therapy for sepsis - biological plausibility from a critical care perspective (Q36646072) (← links)
- Residual rates of mortality in patients with severe sepsis: a fatality or a new challenge? (Q37355631) (← links)
- Clinical applications of intravenous immunoglobulins (IVIg)--beyond immunodeficiencies and neurology. (Q37626123) (← links)
- Immunoglobulins in adult sepsis and septic shock (Q38034107) (← links)
- Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). (Q38207933) (← links)
- Influence of the serum levels of immunoglobulins on clinical outcomes in medical intensive-care patients. (Q40197594) (← links)
- Targeting the Blood-Brain Barrier to Prevent Sepsis-Associated Cognitive Impairment (Q64064138) (← links)
- Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO) (Q64109219) (← links)
- The clinical efficacy of intravenous IgM-enriched immunoglobulin (pentaglobin) in sepsis or septic shock: a meta-analysis with trial sequential analysis (Q64232699) (← links)
- [Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?] (Q81365899) (← links)